GP
GlaxoSmithKline PLC ADR
🇬🇧XLON.GSKUnited KingdomHealthcare
£1,865.50GBPup +11.50 (+0.62%)ClosedEnd of day3:10 AM
Price£1,865.50+11.50 (+0.62%)
Profile
- Healthcare
- Drug Manufacturers - General
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- GB00BN7SWP63
- CUSIP
- Not reported
Company
- Employees
- 66,841
- Headquarters
- London, United States
- Website
- https://www.gsk.com
- CEO
- Mr. Luke Victor Miels
Market
- Shares outstanding
- 4B
- Market cap
- £7.47T
Key dates
- Next earnings
- Oct 28, 2026
Highlights
- Market cap
- £7.43T
- EPS LTM
- $2.37
- P/E LTM
- 16.42
- Div yield
- 3.67%
Fundamentals (LTM)
- Revenue
- $33.2B+4.97%up year on year
- Net income
- $4.82B+40.84%up year on year
- Gross margin
- 72.73%+1.91%up year on year
- Free cash flow
- $6.98B+49.59%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.